- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Novo Nordisk A/S+ Add to Watchlist
NVO:US178.6500 USD 0.0400 0.02%
As of 20:04:07 ET on 12/06/2013.
Company Profile for Novo Nordisk A/S (NVO)
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
Novo Nordisk A/S
Key Executives for Novo Nordisk A/S (NVO)
|Lars Rebien SorensenPresident/CEO||Jesper BrandgaardExec VP/CFO|
|Kaare SchultzExec VP/COO||Mads Krogsgaard ThomsenExec VP/Chief Science Officer|
|Lise KingoExec VP/Chief of Staffs||Lars Fruergaard JorgensenExecutive VP/CIO|
|Jakob RiisExecutive VP||Kasper Roseeuw PoulsenVP/Head:Investor Relations|